Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Nonacus

Tracked across 1 events · 6 articles · First seen Sep 02, 2026 · Last active Sep 04, 2026

Sentiment
85
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 85
Tech
A study published in European Urology Oncology, led by the University of Birmingham and diagnostics company Nonacus, found that the GALEAS Bladder urine test detected 92% of bladder cancers in a real-world NHS trial involving…
Impact: Commercialized the GALEAS Bladder test and is the primary beneficiary. The study validates its product, potentially increasing sales and market share in bladder cancer diagnostics.
Sep 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Nonacus live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.